or Try an Advanced Search...

    Technical Analysis for MAIA - MAIA Biotechnology, Inc.

    Grade Last Price % Change Price Change
    F 2.23 1.83% 0.04
    MAIA closed up 1.83 percent on Wednesday, November 20, 2024, on 43 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical MAIA trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    NR7 Range Contraction 1.83%
    NR7-2 Range Contraction 1.83%
    Wide Bands Range Expansion 1.83%
    Oversold Stochastic Weakness 1.83%
    Slingshot Bearish Bearish Swing Setup -5.11%
    Older End-of-Day Signals for MAIA ...

       Recent Intraday Alerts

    Alert Time
    Up 5% about 18 hours ago
    Up 3% about 18 hours ago
    Up 2% about 18 hours ago
    Up 1% about 18 hours ago
    Down 5% 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    MAIA Chart by TradingView
    Basic chart:

    Profile

    MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Immunogen

    Is MAIA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 7 MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement
    Nov 5 MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
    Oct 15 MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics
    Sep 10 MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer
    Sep 4 MAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference
    Jul 23 Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Jun 7 MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
    Jun 6 MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
    Jun 4 Recent Run-Up Provides MAIA Biotechnology With Breathing Room
    Jun 4 MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
    See more MAIA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.99
    52 Week Low 0.82
    Average Volume 132,323
    200-Day Moving Average 2.76
    50-Day Moving Average 2.69
    20-Day Moving Average 2.64
    10-Day Moving Average 2.50
    Average True Range 0.27
    RSI (14) 39.02
    ADX 20.14
    +DI 18.92
    -DI 32.75
    Chandelier Exit (Long, 3 ATRs) 2.67
    Chandelier Exit (Short, 3 ATRs) 2.61
    Upper Bollinger Bands 3.29
    Lower Bollinger Band 1.99
    Percent B (%b) 0.18
    BandWidth 48.93
    MACD Line -0.13
    MACD Signal Line -0.06
    MACD Histogram -0.07
    Fundamentals Value
    Market Cap 37.83 Million
    Num Shares 17 Million
    EPS -1.44
    Price-to-Earnings (P/E) Ratio -1.55
    Price-to-Sales 0.00
    Price-to-Book 9.14
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.40
    Resistance 3 (R3) 2.41 2.36 2.37
    Resistance 2 (R2) 2.36 2.31 2.35 2.36
    Resistance 1 (R1) 2.29 2.29 2.33 2.29 2.35
    Pivot Point 2.24 2.24 2.26 2.24 2.24
    Support 1 (S1) 2.18 2.20 2.21 2.17 2.11
    Support 2 (S2) 2.13 2.17 2.12 2.10
    Support 3 (S3) 2.06 2.13 2.09
    Support 4 (S4) 2.06